Amy S. Ripka

412 total citations
6 papers, 334 citations indexed

About

Amy S. Ripka is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Amy S. Ripka has authored 6 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Organic Chemistry and 2 papers in Oncology. Recurrent topics in Amy S. Ripka's work include Chemical Synthesis and Analysis (5 papers), Biochemical and Structural Characterization (2 papers) and Peptidase Inhibition and Analysis (2 papers). Amy S. Ripka is often cited by papers focused on Chemical Synthesis and Analysis (5 papers), Biochemical and Structural Characterization (2 papers) and Peptidase Inhibition and Analysis (2 papers). Amy S. Ripka collaborates with scholars based in United States. Amy S. Ripka's co-authors include Daniel H. Rich, Regine S. Bohacek, Kenneth A. Satyshur, M. G. Finn, David Díaz Díaz, Peter W. Glunz, Natalie A. Dales, Yuping Qiu, Julie A. Lemm and Nicholas A. Meanwell and has published in prestigious journals such as Organic Letters, Current Opinion in Chemical Biology and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Amy S. Ripka

6 papers receiving 320 citations

Peers

Amy S. Ripka
Gabor Butora United States
R. Alan Chrusciel United States
Dennis V. Nazareno United States
John J. Court United States
Christine M. Tarby United States
Mary M. Senior United States
Douglas A. Bergman Australia
Karen M. Worthy United States
Anthony R. Gangloff United States
Cliff C. Cheng United States
Gabor Butora United States
Amy S. Ripka
Citations per year, relative to Amy S. Ripka Amy S. Ripka (= 1×) peers Gabor Butora

Countries citing papers authored by Amy S. Ripka

Since Specialization
Citations

This map shows the geographic impact of Amy S. Ripka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy S. Ripka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy S. Ripka more than expected).

Fields of papers citing papers by Amy S. Ripka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy S. Ripka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy S. Ripka. The network helps show where Amy S. Ripka may publish in the future.

Co-authorship network of co-authors of Amy S. Ripka

This figure shows the co-authorship network connecting the top 25 collaborators of Amy S. Ripka. A scholar is included among the top collaborators of Amy S. Ripka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy S. Ripka. Amy S. Ripka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Lopez, Omar D., Van N. Nguyen, Denis R. St. Laurent, et al.. (2012). HCV NS5A replication complex inhibitors. Part 3 : discovery of potent analogs with distinct core topologies. Bioorganic & Medicinal Chemistry Letters. 23(3). 779–784. 23 indexed citations
2.
Ripka, Amy S., et al.. (2003). First Practical Synthesis of Formamidine Ureas and Derivatives. Organic Letters. 5(9). 1531–1533. 13 indexed citations
3.
Ripka, Amy S., Kenneth A. Satyshur, Regine S. Bohacek, & Daniel H. Rich. (2001). Aspartic Protease Inhibitors Designed from Computer-Generated Templates Bind As Predicted. Organic Letters. 3(15). 2309–2312. 30 indexed citations
4.
Ripka, Amy S. & Daniel H. Rich. (1998). Peptidomimetic design. Current Opinion in Chemical Biology. 2(4). 441–452. 200 indexed citations
5.
Ripka, Amy S., Regine S. Bohacek, & Daniel H. Rich. (1998). Synthesis of novel cyclic protease inhibitors using Grubbs olefin metathesis. Bioorganic & Medicinal Chemistry Letters. 8(4). 357–360. 56 indexed citations
6.
Rich, Daniel H., Regine S. Bohacek, Natalie A. Dales, Peter W. Glunz, & Amy S. Ripka. (1997). Transformation of Peptides into Non-Peptides. Synthesis of Computer-Generated Enzyme Inhibitors. CHIMIA International Journal for Chemistry. 51(1-2). 45–45. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gabor Butora Breakdown of academic impact, for papers by R. Alan Chrusciel Breakdown of academic impact, for papers by Dennis V. Nazareno Breakdown of academic impact, for papers by John J. Court Breakdown of academic impact, for papers by Christine M. Tarby Breakdown of academic impact, for papers by Mary M. Senior Breakdown of academic impact, for papers by Douglas A. Bergman Breakdown of academic impact, for papers by Karen M. Worthy Breakdown of academic impact, for papers by Anthony R. Gangloff Breakdown of academic impact, for papers by Cliff C. Cheng
Rankless by CCL
2026